{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T14:32:29Z","timestamp":1793975549232,"version":"4.8.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T00:00:00Z","timestamp":1592179200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T00:00:00Z","timestamp":1592179200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 AG024904"],"award-info":[{"award-number":["U01 AG024904"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-12-2-0012"],"award-info":[{"award-number":["W81XWH-12-2-0012"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Alzheimer\u2019s disease (AD) is a chronic progressive neurodegenerative disease impacting an estimated 44 million adults worldwide. The causal pathology of AD (accumulation of amyloid-beta and tau), precedes hallmark symptoms of dementia by more than a decade, necessitating development of early diagnostic markers of disease onset, particularly for new drugs that aim to modify disease processes. To evaluate differentially methylated positions (DMPs) as novel blood-based biomarkers of AD, we used a subset of 653 individuals with peripheral blood (PB) samples in the Alzheimer\u2019s disease Neuroimaging Initiative (ADNI) consortium. The selected cohort of AD, mild cognitive impairment (MCI), and age-matched healthy controls (CN) all had imaging, genetics, transcriptomics, cerebrospinal protein markers, and comprehensive clinical records, providing a rich resource of concurrent multi-omics and phenotypic information on a well-phenotyped subset of ADNI participants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In this manuscript, we report cross-diagnosis differential peripheral DNA methylation in a cohort of AD, MCI, and age-matched CN individuals with longitudinal DNA methylation measurements. Epigenome-wide association studies (EWAS) were performed using a mixed model with repeated measures over time with a\n                      <jats:italic>P<\/jats:italic>\n                      value cutoff of 1 \u00d7 10\n                      <jats:sup>\u22125<\/jats:sup>\n                      to test contrasts of pairwise differential peripheral methylation in AD vs CN, AD vs MCI, and MCI vs CN. The most highly significant differentially methylated loci also tracked with Mini Mental State Examination (MMSE) scores. Differentially methylated loci were enriched near brain and neurodegeneration-related genes (e.g.,\n                      <jats:italic>BDNF, BIN1, APOC1<\/jats:italic>\n                      ) validated using the genotype tissue expression project portal (GTex).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our work shows that peripheral differential methylation between age-matched subjects with AD relative to healthy controls will provide opportunities to further investigate and validate differential methylation as a surrogate of disease. Given the inaccessibility of brain tissue, the PB-associated methylation marks may help identify the stage of disease and progression phenotype, information that would be central to bringing forward successful drugs for AD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13148-020-00864-y","type":"journal-article","created":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T07:04:28Z","timestamp":1592204668000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":98,"title":["Harnessing peripheral DNA methylation differences in the Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI) to reveal novel biomarkers of disease"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3857-8812","authenticated-orcid":false,"given":"Aparna","family":"Vasanthakumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin W.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Idler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey F.","family":"Waring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Asque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget","family":"Riley-Gillis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaun","family":"Grosskurth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyan","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungeun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwangsik","family":"Nho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly N. H.","family":"Nudelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelley","family":"Faber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana M.","family":"Foroud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol","family":"Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liana G.","family":"Apostolova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqin S.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Saykin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,15]]},"reference":[{"key":"864_CR1","unstructured":"Prince M, Wimo A, Guerchet M, Ali G-C, Wu Y-T, Prina M, et al. The global impact of dementia an analysis of prevalence, incidence, cost and trends. World Alzheimer Rep. 2015;2015."},{"key":"864_CR2","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.pharep.2015.07.006","volume":"68","author":"J Godyn","year":"2016","unstructured":"Godyn J, Jonczyk J, Panek D, Malawska B. Therapeutic strategies for Alzheimer\u2019s disease in clinical trials. Pharmacol Rep. 2016;68:127\u201338.","journal-title":"Pharmacol Rep"},{"key":"864_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2016.00158","volume":"7","author":"S Lehmann","year":"2016","unstructured":"Lehmann S, Teunissen CE. Editorial: Biomarkers of Alzheimer\u2019s disease: the present and the future. Front Neurol. 2016;7:1\u20133.","journal-title":"Front Neurol"},{"key":"864_CR4","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.jalz.2015.05.009","volume":"11","author":"AJ Saykin","year":"2015","unstructured":"Saykin AJ, Shen L, Yao X, Kim S, Nho K, Risacher SL, et al. Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans. Alzheimers Dement. 2015;11:792\u2013814.","journal-title":"Alzheimers Dement"},{"key":"864_CR5","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jalz.2016.11.007","volume":"13","author":"MW Weiner","year":"2017","unstructured":"Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, et al. Recent publications from the Alzheimer\u2019s Disease Neuroimaging Initiative: reviewing progress toward improved AD clinical trials. Alzheimers Dement. 2017;13:e1\u201385 Elsevier.","journal-title":"Alzheimers Dement"},{"key":"864_CR6","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/nrg.2016.59","volume":"17","author":"CD Allis","year":"2016","unstructured":"Allis CD, Jenuwein T. The molecular hallmarks of epigenetic control. Nat Rev Genet. 2016;17:487\u2013500 Nature Publishing Group.","journal-title":"Nat Rev Genet"},{"key":"864_CR7","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1126\/science.6254144","volume":"210","author":"A Razin","year":"1980","unstructured":"Razin A, Riggs AD. DNA methylation and gene function. Science. 1980;210:604\u201310.","journal-title":"Science."},{"key":"864_CR8","doi-asserted-by":"crossref","unstructured":"Klein CJ, Botuyan M, Wu Y, Ward CJ, Nicholson GA, Hammans S, et al. Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss Christopher. 2011;27:819\u201326.","DOI":"10.1038\/ng.830"},{"key":"864_CR9","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/13810","volume":"23","author":"RE Amir","year":"1999","unstructured":"Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet. 1999;23:185\u20138.","journal-title":"Nat Genet"},{"key":"864_CR10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cbpa.2018.02.006","volume":"45","author":"RR Meehan","year":"2018","unstructured":"Meehan RR, Thomson JP, Lentini A, Nestor CE, Pennings S. DNA methylation as a genomic marker of exposure to chemical and environmental agents. Curr Opin Chem Biol. 2018;45:48\u201356 Elsevier Ltd.","journal-title":"Curr Opin Chem Biol"},{"key":"864_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.envint.2018.02.014","volume":"114","author":"R Barouki","year":"2018","unstructured":"Barouki R, Mel\u00e9n E, Herceg Z, Beckers J, Chen J, Karagas M, et al. Epigenetics as a mechanism linking developmental exposures to long-term toxicity. Environ Int. 2018;114:77\u201386 Elsevier.","journal-title":"Environ Int"},{"key":"864_CR12","doi-asserted-by":"crossref","unstructured":"Delgado-Morales R, Esteller M. Opening up the DNA methylome of dementia. Mol Psychiatry. 2016; In press. Nature Publishing Group.","DOI":"10.1038\/mp.2016.242"},{"key":"864_CR13","first-page":"42","volume":"38","author":"Roubroeks","year":"2017","unstructured":"Roubroeks, Lunnon K. Epigenetics and DNA methylomic profiling in Alzheimer\u2019s disease and other neurodegenerative diseases. J Neurochem. 2017;38:42\u20139.","journal-title":"J Neurochem"},{"key":"864_CR14","doi-asserted-by":"crossref","unstructured":"Qazi TJ, Quan Z, Mir A, Qing H. Epigenetics in Alzheimer\u2019s disease: perspective of DNA methylation. Mol Neurobiol. 2017.","DOI":"10.1007\/s12035-016-0357-6"},{"key":"864_CR15","doi-asserted-by":"crossref","unstructured":"Fransquet PD, Lacaze P, Saffery R, McNeil J, Woods R, Ryan J. Blood DNA methylation as a potential biomarker of dementia: A systematic review. Alzheimers Dement. 2017:1\u201323 Elsevier Inc.","DOI":"10.1016\/j.jalz.2017.10.002"},{"key":"864_CR16","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1038\/nn.3782","volume":"17","author":"K Lunnon","year":"2014","unstructured":"Lunnon K, Smith R, Hannon E, De Jager PL, Srivastava G, Volta M, et al. Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer\u2019s disease. Nat Neurosci. 2014;17:1164\u201370 Nature Publishing Group.","journal-title":"Nat Neurosci"},{"key":"864_CR17","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1038\/nn.3786","volume":"17","author":"PL De Jager","year":"2014","unstructured":"De Jager PL, Srivastava G, Lunnon K, Burgess J, Schalkwyk LC, Yu L, et al. Alzheimer\u2019s disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci. Nat Neurosci. 2014;17:1156\u201363 Nature Publishing Group.","journal-title":"Nat Neurosci"},{"key":"864_CR18","doi-asserted-by":"publisher","first-page":"R43","DOI":"10.1186\/gb-2012-13-6-r43","volume":"13","author":"MN Davies","year":"2012","unstructured":"Davies MN, Volta M, Pidsley R, Lunnon K, Dixit A, Lovestone S, et al. Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood. Genome Biol. 2012;13:R43.","journal-title":"Genome Biol"},{"key":"864_CR19","doi-asserted-by":"crossref","unstructured":"Aryee MJ, Liu W, Engelmann JC, Nuhn P, Gurel M, Haffner MC, et al. DNA methylation alterations exhibit intra-individual stability and inter-individual heterogeneity in prostate cancer metastases. Sci Transl Med. 2013;5.","DOI":"10.1126\/scitranslmed.3005211"},{"key":"864_CR20","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1523\/JNEUROSCI.4488-13.2014","volume":"34","author":"X Xu","year":"2014","unstructured":"Xu X, Wells AB, O\u2019Brien DR, Nehorai A, Dougherty JD. Cell type-specific expression analysis to identify putative cellular mechanisms for neurogenetic disorders. J Neurosci. 2014;34:1420\u201331.","journal-title":"J Neurosci"},{"key":"864_CR21","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.1093\/nar\/gkq130","volume":"38","author":"JD Dougherty","year":"2010","unstructured":"Dougherty JD, Schmidt EF, Nakajima M, Heintz N. Analytical approaches to RNA profiling data for the identification of genes enriched in specific cells. Nucleic Acids Res. 2010;38:4218\u201330.","journal-title":"Nucleic Acids Res"},{"key":"864_CR22","doi-asserted-by":"crossref","unstructured":"Aberg KA, Shabalin AA, Chan RF, Zhao M, Kumar G, van Grootheest G, et al. Convergence of evidence from a methylome-wide CpG-SNP association study and GWAS of major depressive disorder. Transl Psychiatry. 2018;8 Springer US.","DOI":"10.1038\/s41398-018-0205-8"},{"key":"864_CR23","doi-asserted-by":"crossref","unstructured":"Ciuculete DM, Bostr\u00f6m AE, Voisin S, Philipps H, Titova OE, Bandstein M, et al. A methylome-wide mQTL analysis reveals associations of methylation sites with GAD1 and HDAC3 SNPs and a general psychiatric risk score. Transl Psychiatry. 2017;7 Nature Publishing Group.","DOI":"10.1038\/tp.2016.275"},{"key":"864_CR24","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1101\/gr.119867.110","volume":"22","author":"F Prosper","year":"2012","unstructured":"Prosper F, Agirre X, Fernandez AF, Assenov Y, Martin-Subero JI, Balint B, et al. A DNA methylation fingerprint of 1628 human samples. Genome Res. 2012;22:407\u201319.","journal-title":"Genome Res"},{"key":"864_CR25","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1080\/15592294.2015.1100786","volume":"10","author":"E Hannon","year":"2015","unstructured":"Hannon E, Lunnon K, Schalkwyk L, Mill J. Interindividual methylomic variation across blood, cortex, and cerebellum: Implications for epigenetic studies of neurological and neuropsychiatric phenotypes. Epigenetics. 2015;10:1024\u201332.","journal-title":"Epigenetics."},{"key":"864_CR26","doi-asserted-by":"crossref","unstructured":"Braun PR, Han S, Hing B, Nagahama Y, Gaul LN, Heinzman JT, et al. Genome-wide DNA methylation comparison between live human brain and peripheral tissues within individuals. Transl Psychiatry. 2019;9.","DOI":"10.1038\/s41398-019-0376-y"},{"key":"864_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13072-015-0011-y","volume":"8","author":"P Farr\u00e9","year":"2015","unstructured":"Farr\u00e9 P, Jones MJ, Meaney MJ, Emberly E, Turecki G, Kobor MS. Concordant and discordant DNA methylation signatures of aging in human blood and brain. Epigenetics Chromatin. 2015;8:1\u201317.","journal-title":"Epigenetics Chromatin"},{"key":"864_CR28","doi-asserted-by":"publisher","first-page":"e1187","DOI":"10.1038\/tp.2017.171","volume":"7","author":"RD Edgar","year":"2017","unstructured":"Edgar RD, Jones MJ, Meaney MJ, Turecki G, Kobor MS. BECon: A tool for interpreting DNA methylation findings from blood in the context of brain. Transl Psychiatry. 2017;7:e1187\u201310 Nature Publishing Group.","journal-title":"Transl Psychiatry"},{"key":"864_CR29","doi-asserted-by":"publisher","first-page":"R97","DOI":"10.1186\/gb-2012-13-10-r97","volume":"13","author":"S Horvath","year":"2012","unstructured":"Horvath S, Zhang Y, Langfelder P, Kahn RS, Boks MP, van Eijk K, et al. Aging effects on DNA methylation modules in human brain and blood tissue. Genome Biol. 2012;13:R97.","journal-title":"Genome Biol"},{"key":"864_CR30","volume-title":"Epigenome-wide meta-analysis of blood DNA methylation and its association with subcortical volumes: findings from the ENIGMA Epigenetics Working Group","author":"T Jia","year":"2019","unstructured":"Jia T. Epigenome-wide meta-analysis of blood DNA methylation and its association with subcortical volumes: findings from the ENIGMA Epigenetics Working Group; 2019."},{"key":"864_CR31","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jalz.2010.03.013","volume":"6","author":"AJ Saykin","year":"2010","unstructured":"Saykin AJ, Shen L, Foroud TM, Potkin SG, Swaminathan S, Kim S, et al. Alzheimer\u2019s disease neuroimaging initiative biomarkers as quantitative phenotypes: genetics core aims, progress, and plans. Alzheimers Dement. 2010;6:265\u201373 Elsevier Ltd.","journal-title":"Alzheimers Dement"},{"key":"864_CR32","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.neurobiolaging.2017.08.010","volume":"60","author":"E Horgusluoglu-Moloch","year":"2017","unstructured":"Horgusluoglu-Moloch E, Nho K, Risacher SL, Kim S, Foroud T, Shaw LM, et al. Targeted neurogenesis pathway-based gene analysis identifies ADORA2A associated with hippocampal volume in mild cognitive impairment and Alzheimer\u2019s disease. Neurobiol Aging. 2017;60:92\u2013103 Elsevier Inc.","journal-title":"Neurobiol Aging"},{"key":"864_CR33","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1001\/jamaneurol.2017.4198","volume":"75","author":"LG Apostolova","year":"2018","unstructured":"Apostolova LG, Risacher SL, Duran T, Stage EC, Goukasian N, West JD, et al. Associations of the top 20 Alzheimer disease risk variants with brain amyloidosis. JAMA Neurol. 2018;75:328\u201341.","journal-title":"JAMA Neurol"},{"key":"864_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10238-017-0467-0","volume":"18","author":"Y Pan","year":"2018","unstructured":"Pan Y, Liu G, Zhou F, Su B, Li Y. DNA methylation profiles in cancer diagnosis and therapeutics. Clin Exp Med. 2018;18:1\u201314 Springer International Publishing.","journal-title":"Clin Exp Med"},{"key":"864_CR35","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1053\/j.gastro.2019.01.270","volume":"156","author":"HK Somineni","year":"2019","unstructured":"Somineni HK, Venkateswaran S, Kilaru V, Marigorta UM, Mo A, Okou DT, et al. Blood-Derived DNA Methylation Signatures of Crohn\u2019s Disease and Severity of Intestinal Inflammation. Gastroenterology. 2019;156:2254\u20132265.e3.","journal-title":"Gastroenterology"},{"key":"864_CR36","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1161\/CIRCULATIONAHA.117.027355","volume":"136","author":"B Meder","year":"2017","unstructured":"Meder B, Haas J, Sedaghat-Hamedani F, Kayvanpour E, Frese K, Lai A, et al. Epigenome-Wide Association Study Identifies Cardiac Gene Patterning and a Novel Class of Biomarkers for Heart Failure. Circulation. 2017;136:1528\u201344.","journal-title":"Circulation."},{"key":"864_CR37","doi-asserted-by":"publisher","first-page":"585","DOI":"10.2217\/epi-2017-0132","volume":"10","author":"L Chouliaras","year":"2018","unstructured":"Chouliaras L, Pishva E, Haapakoski R, Zsoldos E, Mahmood A, Filippini N, et al. Peripheral DNA methylation, cognitive decline and brain aging: Pilot findings from the Whitehall II imaging study. Epigenomics. 2018;10:585\u201395.","journal-title":"Epigenomics."},{"key":"864_CR38","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1001\/archneurol.2011.123","volume":"68","author":"RY Lo","year":"2011","unstructured":"Lo RY, Hubbard AE, Shaw LM, Trojanowski JQ, Petersen RC, Aisen PS, et al. Longitudinal change of biomarkers in cognitive decline. Arch Neurol. 2011;68:1257\u201366.","journal-title":"Arch Neurol"},{"key":"864_CR39","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.3233\/JAD-170511","volume":"60","author":"J Dumurgier","year":"2018","unstructured":"Dumurgier J, Hanseeuw BJ, Hatling FB, Judge KA, Schultz AP, Chhatwal JP, Blacker D, Sperling RA, Johnson KA, Hyman BTG-IT. Alzheimer\u2019s Biomarkers and Future Decline in Cognitive Normal Older Adults. J Alzheimers Dis. 2018;60:1451\u20139.","journal-title":"J Alzheimers Dis"},{"key":"864_CR40","first-page":"201","volume-title":"Alzheimer \u2019 s Disease Neuroimaging Initiative ( ADNI ) Clinical characterization","author":"RC Petersen","year":"2011","unstructured":"Petersen RC, Aisen PS, Beckett LA. Alzheimer \u2019 s Disease Neuroimaging Initiative ( ADNI ) Clinical characterization; 2011. p. 201\u20139."},{"key":"864_CR41","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/1471-2164-14-293","volume":"14","author":"R Pidsley","year":"2013","unstructured":"Pidsley R, Wong CCY, Volta M, Lunnon K, Mill J, Schalkwyk LC. A data-driven approach to preprocessing Illumina 450 K methylation array data. BMC Genomics. 2013;14:293.","journal-title":"BMC Genomics"},{"key":"864_CR42","doi-asserted-by":"publisher","first-page":"3982","DOI":"10.1093\/bioinformatics\/btx513","volume":"33","author":"Y Tian","year":"2017","unstructured":"Tian Y, Morris TJ, Webster AP, Yang Z, Beck S, Feber A, et al. ChAMP: Updated methylation analysis pipeline for Illumina BeadChips. Bioinformatics. 2017;33:3982\u20134.","journal-title":"Bioinformatics."},{"key":"864_CR43","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/bioinformatics\/btw691","volume":"33","author":"JP Fortin","year":"2017","unstructured":"Fortin JP, Triche TJ, Hansen KD. Preprocessing, normalization and integration of the Illumina HumanMethylationEPIC array with minfi. Bioinformatics. 2017;33:558\u201360.","journal-title":"Bioinformatics."},{"key":"864_CR44","volume-title":"Methylumi: Handle Illumina methylation data. R package version 2.32.0","author":"S Davis","year":"2019","unstructured":"Davis S, Du P, Bilke S, Triche T Jr, Bootwalla M. Methylumi: Handle Illumina methylation data. R package version 2.32.0; 2019."},{"key":"864_CR45","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.","journal-title":"Nucleic Acids Res"},{"key":"864_CR46","doi-asserted-by":"crossref","unstructured":"Phipson B, Lee S, Majewski IJ, Alexander WS, Smyth G. Robust hyperparameter estimation protects. 2016;10:946\u201363.","DOI":"10.1214\/16-AOAS920"},{"key":"864_CR47","doi-asserted-by":"crossref","unstructured":"Liu R, Holik AZ, Su S, Jansz N, Chen K, Leong HS, et al. Why weight? Modelling sample and observational level variability improves power in RNA-seq analyses. Nucleic Acids Res. 2015;43.","DOI":"10.1093\/nar\/gkv412"},{"key":"864_CR48","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1093\/bioinformatics\/bti270","volume":"21","author":"GK Smyth","year":"2005","unstructured":"Smyth GK, Michaud J, Scott HS. Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics. 2005;21:2067\u201375.","journal-title":"Bioinformatics."},{"key":"864_CR49","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci"},{"key":"864_CR50","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","volume":"27","author":"A Liberzon","year":"2011","unstructured":"Liberzon A, Subramanian A, Pinchback R, Thorvaldsd\u00f3ttir H, Tamayo P, Mesirov JP. Molecular signatures database (MSigDB) 3.0. Bioinformatics. 2011;27:1739\u201340.","journal-title":"Bioinformatics."}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-020-00864-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-020-00864-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-020-00864-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T07:07:12Z","timestamp":1696230432000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-020-00864-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,15]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["864"],"URL":"https:\/\/doi.org\/10.1186\/s13148-020-00864-y","relation":{},"ISSN":["1868-7075","1868-7083"],"issn-type":[{"value":"1868-7075","type":"print"},{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,15]]},"assertion":[{"value":"4 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The institutional review boards of all participating ADNI sites reviewed and approved the data collection protocol provided by ADNI. For up-to-date information, see","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AV, JWD, KI, EA, BRG, SG, GS, and JFW are all employees of AbbVie and may hold stock. YS, QSL are employees of Janssen, and KE was an employee of Biogen.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"84"}}